Product Information
MAPAP 500 MG CAPSULE is a generic product labeled by Major Pharmaceuticals, priced at $0.0348 per EA under NDC 00904198760. Its NADAC has been published 671 times since Nov 28, 2013.
Strength
500 mg/1
Manufacturer
Major PharmaceuticalsNDC
00904198760
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ACETAMINOPHENApproval Type
OTC MONOGRAPH DRUG
FDA Application
M013On Market Since
12/22/1997
Price Statistics
The NADAC for MAPAP 500 MG CAPSULE has been published 671 times since Nov 28, 2013, and over the history we have for it it has risen 2.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0348 per EA |
|---|---|
| All-time high | $0.0691 (Jul 12, 2017) |
| All-time low | $0.0278 (Aug 22, 2018) |
| 52-week high | $0.0362 |
| 52-week low | $0.0348 |
| Median price | $0.0362 |
| Average price | $0.0395 |
| Largest weekly change | +56.6% (Jun 21, 2017) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Acetaminophen market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Major Pharmaceuticals manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Acetaminophen market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of MAPAP 500 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for MAPAP 500 MG CAPSULE, manufactured by Major Pharmaceuticals, is $0.0348 per EA (NDC 00904198760), effective Sep 30, 2026.
How has the price of MAPAP 500 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for MAPAP 500 MG CAPSULE has risen 2.6%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for MAPAP 500 MG CAPSULE?
Since Nov 28, 2013, the NADAC for MAPAP 500 MG CAPSULE has ranged from a low of $0.0278 (Aug 22, 2018) to a high of $0.0691 (Jul 12, 2017), with a median of $0.0362 per EA.
Are there cheaper alternatives to MAPAP 500 MG CAPSULE?
No other NADAC-published product currently shares the active ingredient and strength of MAPAP 500 MG CAPSULE in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures MAPAP 500 MG CAPSULE?
MAPAP 500 MG CAPSULE (NDC 00904198760) is labeled by Major Pharmaceuticals, and CMS classifies it as a generic product.